OR WAIT null SECS
July 02, 2013
The US and EU move forward with measures to fortify the pharmaceutical supply chain.
June 26, 2013
Cocrystals can enable the formulation of solid dosage drugs, but the FDA's final guidelines have left concerns about how their use could impact development timelines, the drug product manufacturing process, and the intellectual property position of products containing cocrystals.
June 02, 2013
Researchers at the Scripps Research Institute advance heteorcylic chemistry trhough new reagents and reaction-tracking techniques.
A recent study of computer-created and natural proteins suggests the number of sites where small-molecule drugs can bind to proteins is limited, thereby narrowing how to mitigate side effects through drug design.
Microwave spectroscopy overcomes some of the limitations of circular dichroism and vibrational circular dichroism in analyzing enantiomers.
May 22, 2013
Dynamic testing and advances in shear testing provide better insight into powder physical properties and external variables that affect powder behavior.
May 16, 2013
Access to extremely low and consistently controlled reaction temperatures can improve product yields and selectivities while also reducing costs.
May 02, 2013
The rejection by India's Supreme Court on Novartis' Glivec/Gleevec (imatinib mesylate) and other recent case law raise important issues on patent strategies for solid forms.
Solid-state chemistry is an important part of drug development, and public research is advancing the field.
Cocrystals are used to improve the performance of APIs that have non-ideal physiochemical properties by cocrystallizing the API with a second compound that modulates the API to provide a way to improve a drug's bioavailability, stability, and processability.